Fierce Pharma

MAY 7, 2024

Even after consumer outfit Kenvue split from Johnson & Johnson one year ago, the company has been performing certain services for the pharma and medtech giant as part of a transition process. | Kenvue’s board of directors on Monday approved a plan to cut 4% of the company’s global workforce. The J&J spinoff employed about 23,000 staffers at the end of last year, so the layoff initiative could affect some 920 workers.

Pharma 316

Pharma 316

MedCity News

MAY 7, 2024

There is a growing urgency for alternative solutions that support consumers where they are, and this is where the promise of digital health can be transformative. The post Tech-Driven Healthcare: Paving the Way for Scalable Solutions appeared first on MedCity News.

Healthcare 129

Healthcare Healthcare 129

Fierce Pharma

MAY 7, 2024

In its opening months, after spinning off as a separate business from Novartis, Sandoz is riding the wave of a strong launch of its biosimilar version of AbbVie’s Humira (adalimumab). | After spinning off as a separate business from Novartis, Sandoz is riding the wave of a strong launch of its biosimilar version of AbbVie’s Humira (adalimumab). With Hyrimoz leading the way, sales of the company’s biosimilars reached $623 million in the first three months of this year.

Leads 282

Leads Sales 282

MedCity News

MAY 7, 2024

More than a third of employers are integrating accountable care into their health benefits, according to a new report from the Milken Institute. However, there are several barriers. The post Report: More Employers Are Looking To Deploy Value-Based Care appeared first on MedCity News.

127

127

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

MAY 7, 2024

While cystic fibrosis has long been Vertex Pharmaceuticals’ bread and butter, the company has been eager to diversify its revenue base in recent years. | As of mid-April, Vertex said it had collected 5 patients' cells for eventual treatment with sickle cell disease therapy Casgevy. That puts Vertex ahead of its gene therapy rival bluebird bio, which recently said it had collected just one patient's cells for its own SCD treatment Lyfgenia.

Pharmaceutical 271

Pharmaceutical Patients 271

pharmaphorum

MAY 7, 2024

Understanding complex scientific studies is often a challenge for patients as well as healthcare professionals, but one that may become easier thanks to artificial intelligence.

Healthcare 117

Healthcare Healthcare Patients 117

MedCity News

MAY 7, 2024

Geneoscopy received approval for its noninvasive colorectal cancer screening test, which the FDA designated as a breakthrough device. This marks only the second time the FDA has issued an approval for a molecular diagnostic test for colorectal cancer — and the first time the agency has done so for a colorectal cancer test that uses RNA. The post FDA Grants First-Ever Approval to an RNA-Based Diagnostic for Colorectal Cancer appeared first on MedCity News.

FDA 113

FDA Biopharma 113

Fierce Pharma

MAY 7, 2024

With $1.1 billion cash on | With $1.1 billion cash on Madrigal Pharmaceuticals’ balance sheet, CEO Bill Sibold believes the company can “fully resource” the launch of Rezdiffra, the first FDA-approved therapy for fatty liver disease.

FDA 184

FDA Pharmaceutical 184

PharmaVoice

MAY 7, 2024

The director of the University of Pittsburgh’s McGowan Institute for Regenerative Medicine believes the industry is “turning a corner.

Medicine 111

Medicine 111

European Pharmaceutical Review

MAY 7, 2024

A novel intravesical targeted drug delivery system for patients with bladder cancer has demonstrated positive data in updated results from a Phase I trial. Johnson & Johnson’s Phase I study is assessing the safety and efficacy of TAR-210 as a delivery method for sustained, local release of erdafitinib into the bladder. The treatment is being evaluated in patients with non–muscle-invasive bladder cancer (NMIBC) with select FGFR alterations.

Food and Drug Administration 97

Food and Drug Administration Patients Food Safety 97

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

MAY 7, 2024

Pfizer has paused dosing in a study of its Duchenne muscular dystrophy gene therapy after a sudden patient death in another trial

Patients 117

Patients 117

European Pharmaceutical Review

MAY 7, 2024

Two new formulations cabotegravir (cabotegravir extended-release injectable suspension and tablets) have been approved by the Medicines and Healthcare products Regulatory Agency ( MHRA ). The treatment consists of Apretude 30mg film-coated tablets and Apretude 600mg prolonged-release suspension for injection. These treatments are indicated for the prevention of sexually transmitted HIV-1 infection — pre-exposure prophylaxis (PrEP) in adults and adolescents weighing at least 35kg with a higher in

Medicine 97

Medicine Healthcare Healthcare Pharmaceutical 97

MedCity News

MAY 7, 2024

This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision making via elevated awareness. With the right tools in place, organizations can expedite strategic achievement across every area of the system. The post Using Informed Awareness to Transform Care Coordination and Improve the Clinical and Patient Experience appeared first on MedCity News.

Patients 102

Patients 102

European Pharmaceutical Review

MAY 7, 2024

A new report by MarketsandMarkets has predicted that the injectable drug delivery market will reach an 8.6 percent compound annual growth rate (CAGR) between 2024 to 2029. The market is anticipated to value $1139.4 billion by 2029. Injectable drugs are adopted widely as treatments for chronic infections such as HIV/AIDS and tuberculosis (TB). Treatment approaches for the latter condition is often a combination of oral antibiotics plus injectable drugs such as rifampin, isoniazid, and streptomyci

Food and Drug Administration 94

Food and Drug Administration Marketing Government Food 94

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

MAY 7, 2024

Two-year data from a phase 1/2 trial of eyeDNA Therapeutics' gene therapy for retinitis pigmentosa sets up pivotal trials, says the new biotech.

104

104

Pharmaceutical Technology

MAY 7, 2024

AstraZeneca has concluded an equity investment in clinical-stage biotechnology company Cellectis following a deal signed in November 2023.

96

96

Pharmaceutical Commerce

MAY 7, 2024

The acquisition, the parties say, will benefit pharma and biotech in the clinical and commercial stages.

Pharma 103

Pharma 103

Pharmaceutical Technology

MAY 7, 2024

A new study has further supported psilocybin's potential to treat depression, which impacts around 300 million people globally.

98

98

Advertisement

PharmaTimes

MAY 7, 2024

The chronic brain disease that causes seizures currently affects around 600,000 people living in the UK

Patients 104

Patients 104

pharmaphorum

MAY 7, 2024

Having two copies of the ApoE4 gene is not just a risk factor for the development of Alzheimer’s, but is a likely cause of the disease, according to researchers in Spain

76

76

PharmaTimes

MAY 7, 2024

The rare and fatal progressive neurodegenerative disease is estimated to affect 5,000 people in the UK

93

93

pharmaphorum

MAY 7, 2024

GSK commits to further support of BioVersys’ TB drug Phil.

109

109

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Technology

MAY 7, 2024

The FTC is cracking down on pharma companies filing sham patents in the Orange Book to delay generics competition.

Pharma 78

Pharma Competition 78

Eversana Intouch

MAY 7, 2024

Asking yourself “what if” can provide a surge of energy to your thoughts – a mental supercharger, if you will. In this blog post, we’ll explore how these two words can not only transform your perspective, but also supercharge your brand plan. What does it mean to ask yourself “what if”? The idea comes from a curiosity to try something new, inspirational, bold or exciting.

Marketing 59

Marketing Pharma Healthcare Healthcare 59

Pharmaceutical Commerce

MAY 7, 2024

The latest news for pharma industry insiders.

Pharma 105

Pharma 105

Clarify Health

MAY 7, 2024

This is part three of our three-part series about how health plan leaders can leverage healthcare claims data to reduce costs , strategically grow their networks , provide best-in-class member services , and enhance outcomes for their members. In healthcare, the shift towards personalized, value-based care is no longer a preference but a necessity.

Healthcare 52

Healthcare Healthcare Patients Competition 52

Advertisement

Distribution

LEVO Health

MAY 7, 2024

Healthcare organizations are increasingly partnering with influencers to build trust with their audience and expand their reach. By collaborating with influencers, healthcare brands can share their message with humanity, connect with consumers personally, and establish credibility within their target communities. Additionally, this marketing avenue helps practices and healthcare providers create meaningful patient relationships, foster loyalty, and drive business growth.

Healthcare 52

Healthcare Healthcare Marketing Healthcare Provider 52

PharmExec

MAY 7, 2024

In this Pharmaceutical Executive video interview, Jesse Mendelsohn, senior vice president at Model N, discusses how more granular insights into channel, tracing, and chargeback data can help drugmakers make smarter provider and payer contracting decisions.

Pharma 52

Pharma Pharmaceutical 52

Pharmacy Times

MAY 7, 2024

As pharmacy practice continues to evolve, it is imperative to recognize the vital contributions of all members of the pharmacy team, including pharmacy technicians.

63

63

PharmExec

MAY 7, 2024

The catheters approved by the FDA include the Plato 17, a DMSO-compatible microcatheter, and the Socrates 38, an aspiration catheter specifically designed for treating ischemic strokes.

FDA 52

FDA 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales